vTv Therapeutics (VTVT) EPS (Basic) (2015 - 2026)
vTv Therapeutics (VTVT) reported EPS (Basic) of $38.78 for Q1 2026, up 1341.42% on a YoY basis from $2.69 in Q1 2025, and up 3529.01% sequentially from -$1.13 in Q4 2025.
vTv Therapeutics (VTVT) EPS (Basic) (2015 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 12 years of EPS (Basic) data on file, last reported at $38.78 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 1341.42% year-over-year to $38.78; the trailing twelve-month figure through Mar 2026 stood at $3.62 (up 131.56% YoY), and the FY2025 full-year result was -$4.27, up 68.66% from the prior year.
- EPS (Basic) rose to $38.78 in Q1 2026, from -$1.13 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $38.78 in Q1 2026 to a low of -$9.09 in Q1 2022.
- A 5-year average of -$1.91 and a median of -$3.96 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) plunged 402.79% in 2022 and surged 1341.42% in 2026, its largest moves.
- Tracing VTVT's EPS (Basic) over 5 years: stood at -$5.48 in 2022, then climbed by 29.69% to -$3.85 in 2023, then soared by 30.28% to -$2.68 in 2024, then surged by 57.87% to -$1.13 in 2025, then jumped by 3529.01% to $38.78 in 2026.
- Business Quant data shows VTVT's EPS (Basic) at $38.78 in Q1 2026, -$1.13 in Q4 2025, and -$1.38 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 0.00 |
| 4 | BeOne Medicines | 468.11 Bn | 463.32 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 122.48 Bn | 115.23 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.55 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | 0.00 |
| 8 | Argenx Se | 55.66 Bn | 50.47 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.42 Bn | 34.41 Bn | 959.66 Mn | 1.55 |
| 10 | vTv Therapeutics | 18.96 Mn | 18.96 Mn | - | 38.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.78 |
| Dec 31, 2025 | -1.13 |
| Sep 30, 2025 | -1.38 |
| Jun 30, 2025 | -3.63 |
| Mar 31, 2025 | -3.12 |
| Dec 31, 2024 | -2.68 |
| Sep 30, 2024 | -3.56 |
| Jun 30, 2024 | -3.96 |
| Mar 31, 2024 | -5.40 |
| Dec 31, 2023 | -3.85 |
| Sep 30, 2023 | -7.42 |
| Jun 30, 2023 | -6.27 |
| Mar 31, 2023 | -5.08 |
| Dec 31, 2022 | -5.48 |
| Sep 30, 2022 | -5.01 |
| Jun 30, 2022 | -4.13 |
| Mar 31, 2022 | -9.09 |
| Dec 31, 2021 | -8.77 |
| Sep 30, 2021 | -1.47 |
| Jun 30, 2021 | -0.82 |